These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28460024)

  • 1. Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.
    Hellwig S; Grittner U; Audebert H; Endres M; Haeusler KG
    Europace; 2018 Apr; 20(4):569-574. PubMed ID: 28460024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pre-admission oral anticoagulation on ischaemic stroke volume, lesion pattern, and frequency of intracranial arterial occlusion in patients with atrial fibrillation.
    Dietzel J; Piper SK; Ruschmann R; Wollboldt C; Usnich T; Hellwig S; Galinovic I; Audebert HJ; Endres M; Villringer K; Fiebach JB; Haeusler KG
    Europace; 2018 Nov; 20(11):1758-1765. PubMed ID: 29165559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
    Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.
    Haeusler KG; Tütüncü S; Kunze C; Schurig J; Malsch C; Harder J; Wiedmann S; Dimitrijeski B; Ebinger M; Hagemann G; Hamilton F; Honermann M; Jungehulsing GJ; Kauert A; Koennecke HC; Leithner C; Mackert BM; Masuhr F; Nabavi D; Rocco A; Schmehl I; Schmitz B; Sparenberg P; Stingele R; von Brevern M; Völzke E; Dietzel J; Heuschmann PU; Endres M
    Europace; 2019 Nov; 21(11):1621-1632. PubMed ID: 31397475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
    JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study.
    Hohnloser SH; Basic E; Nabauer M
    Clin Res Cardiol; 2017 Aug; 106(8):618-628. PubMed ID: 28293797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.
    Itäinen S; Lehto M; Vasankari T; Mustonen P; Kotamäki M; Numminen A; Lahtela H; Bah A; Hartikainen J; Hekkala AM; Airaksinen JKE
    Europace; 2018 Apr; 20(4):565-568. PubMed ID: 29016758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Therapeutic International Normalized Ratio Results in Smaller Infarcts and Better Outcomes for Patients with Ischemic Stroke.
    Merbach D; Lawrence E; Mallick D; Marsh EB
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104278. PubMed ID: 31326271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Dourliou V; Sofogianni A; Savopoulos C; Hatzitolios AI
    J Thromb Thrombolysis; 2016 Feb; 41(2):336-42. PubMed ID: 26253707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
    Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
    Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke.
    Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A
    J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Paciaroni M; Agnelli G; Caso V; Silvestrelli G; Seiffge DJ; Engelter S; De Marchis GM; Polymeris A; Zedde ML; Yaghi S; Michel P; Eskandari A; Antonenko K; Sohn SI; Cappellari M; Tassinari T; Tassi R; Masotti L; Katsanos AH; Giannopoulos S; Acciarresi M; Alberti A; Venti M; Mosconi MG; Vedovati MC; Pierini P; Giustozzi M; Lotti EM; Ntaios G; Kargiotis O; Monaco S; Lochner P; Bandini F; Liantinioti C; Palaiodimou L; Abdul-Rahim AH; Lees K; Mancuso M; Pantoni L; Rosa S; Bertora P; Galliazzo S; Ageno W; Toso E; Angelini F; Chiti A; Orlandi G; Denti L; Flomin Y; Marcheselli S; Mumoli N; Rimoldi A; Verrengia E; Schirinzi E; Del Sette M; Papamichalis P; Komnos A; Popovic N; Zarkov M; Rocco A; Diomedi M; Giorli E; Ciccone A; Mac Grory BC; Furie KL; Bonetti B; Saia V; Guideri F; Acampa M; Martini G; Grifoni E; Padroni M; Karagkiozi E; Perlepe K; Makaritsis K; Mannino M; Maccarrone M; Ulivi L; Giannini N; Ferrari E; Pezzini A; Doronin B; Volodina V; Baldi A; D'Amore C; Deleu D; Corea F; Putaala J; Santalucia P; Nardi K; Risitano A; Toni D; Tsivgoulis G
    Stroke; 2019 Aug; 50(8):2168-2174. PubMed ID: 31234756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.